Development and characterization of an indoleamine 2,3-dioxygenase (IDO) deficient mouse model of preeclampsia

被引:0
|
作者
Santillan, Mark
Pelham, Christopher [1 ]
Ketsawatsomkron, Pimonrat [2 ]
Santillan, Donna
Yang, Baoli
Hunter, Stephen
Sigmund, Curt [2 ]
机构
[1] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA
[2] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
关键词
D O I
10.1016/j.ajog.2009.10.783
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
766
引用
收藏
页码:S276 / S276
页数:1
相关论文
共 50 条
  • [41] Indoleamine 2,3-dioxygenase in transplantation
    Mulley, William R.
    Nikolic-Paterson, David J.
    NEPHROLOGY, 2008, 13 (03) : 204 - 211
  • [42] Indoleamine 2,3-dioxygenase (IDO) supports metastatic outgrowth of the 4T1 breast cancer mouse model
    Smith, Courtney
    Muller, Alexander J.
    DuHadaway, James
    Prendergast, George C.
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 170 - 170
  • [43] Indoleamine 2,3-Dioxygenase Does It
    Hoogduijn, Martin J.
    TRANSPLANTATION, 2015, 99 (09) : 1751 - 1752
  • [44] Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase
    Yoshioka, Saeko
    Ikeda, Tomonori
    Fukuchi, Sogo
    Kawai, Yurika
    Ohta, Katsumi
    Murakami, Hisashi
    Ogo, Naohisa
    Muraoka, Daisuke
    Takikawa, Osamu
    Asai, Akira
    INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2022, 15
  • [45] Indoleamine 2,3-Dioxygenase (IDO) Activity Influence Tumor Growth in the TRAMP Prostate Cancer Model
    Kallberg, Eva
    Wikstrom, Pernilla
    Bergh, Anders
    Ivars, Fredrik
    Leanderson, Tomas
    PROSTATE, 2010, 70 (13): : 1461 - 1470
  • [46] Indoleamine 2,3-Dioxygenase (IDO) Immune Status Monitoring Post-Transplantation
    Dharnidharka, Vikas
    Gupta, Sushil
    Garrett, Timothy
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 25 - 25
  • [47] Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination
    Straten, Per Thor
    Andersen, Mads Hald
    VACCINE, 2011, 29 (21) : 3728 - 3728
  • [48] Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
    Roehrig, Ute F.
    Majjigapu, Somi Reddy
    Vogel, Pierre
    Zoete, Vincent
    Michiein, Olivier
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (24) : 9421 - 9437
  • [49] Understandings of Immunomodulatory Pathways of Indoleamine 2,3-dioxygenase (IDO) in Bladder Cancer Cells
    Gomes Matheus, Luiz Henrique
    Ferreira, Janaina Mendes
    Dalmazzo, Stephanie Vanin
    Pereira, Lucas Alves
    dos Santos, Andressa Assuncao
    Alves Rubens dos Santos, Leticia Rafaela
    Reis, Sabrina Thalita
    Delle, Humberto
    FASEB JOURNAL, 2019, 33
  • [50] Indoleamine 2,3-dioxygenase (IDO):: the antagonist of type IIFN driven skin inflammation?
    Scheler, M.
    Bieber, T.
    Tueting, T.
    Wenzel, J.
    von Bubnoff, D.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 216 - 217